PacBio
Automate DNA extraction
Hybrid
Some members of the team work remotely, while others are co-located in one or more offices.
👥501-1,000
📍Menlo Park, CA
PacBio

About PacBio

About PacBio
About PacBio
About PacBio
About PacBio
About PacBio
PacBio designs, develops, and manufactures sequencing systems.

What PacBio is building

PacBio product / service
PacBio product / service
PacBio product / service
PacBio product / service
PacBio product / service
At PacBio, we’re devoted to empowering you. Pioneering the future through biology takes vision. You have to look beyond the status quo to what’s possible.We know your vision can reveal the full potential of the genome, advance human health and the health of our planet. And that is why your vision and pursuit are at the very center of what our company does — our product design, our customer support model, our partnerships, and even our identity.We create the world’s most advanced sequencing systems to provide you the most complete and accurate view of genomes, transcriptomes, and epigenomes. Our founders invented a new way to study the synthesis and regulation of DNA, RNA, and proteins. Driven by a desire to advance human health, we’re harnessing advances in biochemistry, optics, nanofabrication, and more.We are passionate about developing products that empower scientists to explore the full spectrum of genetic variation in any organism — from unraveling the mystery of rare diseases to improving the world’s food supply. With world-class service and support, we keep your research progressing so you can focus on finding answers.

Technologies used at PacBio

Back-end (6)
LinuxLinux
AWSAWS
ScalaScala
PythonPython
JavaJava
C++C++

Company culture

BE CURIOUS.

Our future depends on it.

DELIGHT OUR CUSTOMERS.

We strive to get it right every time.

See more

Funding rounds

Total Funding

Total Funding

$1.4B
Last funding round type

Last funding round type

Post-IPO Equity
Company type

Company type

For Profit

PacBio news and updates

Chinese University of Hong Kong filed suit against Pacb on Dec 14th 22'.

Software company Take2 Technologies and the Chinese University of Hong Kong filed a patent infringement lawsuit against Pacific Biosciences of California on Wednesday in Delaware District Court.

Dec 15, 2022 | law.com

Childrenshospitalleague partners with Pacb

Boston Children's Hospital is partnering with PacBio to use its HiFi sequencing technology to identify rare pediatric diseases.

Dec 7, 2022 | beckershospitalreview.com

Whipsaw Inc partners with Pacb

Whipsaw partnered with PacBio to identify an all-new user interaction model and to design a stunning new industrial design for the instrument, including an intuitive user interface.

Nov 30, 2022 | core77.com

Pacb launched Revio, Onso, and MAS-Seq on Oct 22nd 22'.

Recently, Pacb announced Revio, Onso, and MAS-Seq, three new products to provide the most accurate long-read, short-read, and single-cell RNA sequencing data possible.

Nov 21, 2022 | pacb.com

Pacb launched Revio long-read sequencing system on Oct 25th 22'.

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the Revio™ long-read sequencing system, which will enable customers to dramatically scale their use of PacBio’s celebrated HiFi sequencing technology.

Oct 24, 2022 | pacb.com

Pacb launched Consortium for Long Read Sequencing on Oct 24th 22'.

PacBio, this month, announced the creation of the Consortium for Long Read Sequencing, which aims to accelerate the utility of long-read human genome datasets.

Oct 24, 2022 | nasdaq.com

Pacb launched Multiplexed Arrays Sequencing kit on Oct 20th 22'.

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the launch of its Multiplexed Arrays Sequencing (MAS-Seq) kit in partnership with the Broad Institute of MIT and Harvard and 10x Genomics, Inc.

Oct 19, 2022 | imoscancer.org

Pacb launched line of high-throughput long-read gene panels on Oct 19th 22'.

Sequencing company PacBio, and synthetic DNA company Twist Bioscience announced today the launch of a line of high-throughput long-read gene panels.

Oct 19, 2022 | insideprecisionmedicine.com

Pacb is developing Alliance panels

PacBio and Twist collaborated with researchers at leading institutions to develop two Alliance panels.

Oct 18, 2022 | pacb.com

Pacb partnered with Robotic Biology Institute Inc. on May 9th 22'.

This May, PacBio announced a team up with iLAC and the Robotic Biology Institute to develop end-to-end automated workflows for its sequencing platforms, the Robotic Biology Institute is looking for ways to integrate its LabDroid humanoid robot into sequencing flows to achieve 24/7 uninterrupted high throughput capabilities.

May 8, 2022 | prnasia.com

Pacb hires Michael Eberle as Vice President of Computational Biology

PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing platforms, welcomes Michael Eberle, Ph.D., as Vice President of Computational Biology.

Jan 1, 2022 | pacb.com

Pacb launches Sequel II based clinical program

“Since Pacb launched the Sequel II based clinical program in China, Pacb has seen great interest and excitement from the medical community.

Jan 1, 2022 | pacb.com

Pacb partnered with Corteva, Inc. on Apr 4th 22'.

PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, announced today a new collaboration with global agriculture company, Corteva Agriscience, to develop custom, end-to-end workflows for plant, pest and microbial sequencing.

Jan 1, 2022 | pacb.com

Pacb launched SMRT Link v11.0 on Apr 21st 22'.

Today, Pacb is excited to share the latest milestone in this pursuit with the launch of SMRT Link v11.0.

Jan 1, 2022 | pacb.com

Pacb launches single-reaction sequencing plate and SMRT Cell 8M tray

PacBio also introduced a new single-reaction sequencing plate and SMRT Cell 8M tray that better enables customers to run samples at their convenience.

Jan 1, 2022 | pacb.com

Pacb hires Jeff

"Jeff is joining PacBio at a critical time as we continue in our efforts to expand our sequencing portfolio to become a multiplatform solution provider, scale our global commercial footprint and move towards profitability.

Jan 1, 2022 | prnewswire.com

Canada Pension Plan Investments invests into Pacb

Canada Pension Plan Investment Board has invested 0.01% in Pacific Biosciences of California, Inc. (NASDAQ:PACB).

Jan 1, 2019 | makdaily.com
See More